Ticagrelor and Anti-inflammatory Effects

NCT02406911 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Ticagrelor

Sponsor

Kyunghee University Medical Center